Trade TDAC stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Translational Development Acquisition Corp. (TDAC) is trading at US$10.86, down 0.37% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$209.4M. Over the past 52 weeks, TDAC has traded between US$10.34 and US$10.95. On Syfe you can trade TDAC with $0 commission and add it to your watchlist.
| Previous close | US$10.90 |
|---|---|
| Market cap | US$209.4M |
| 52-week range | US$10.34 – US$10.95 |
| Volume | 15.58K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Translational Development Acquisition Corp.
Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 19, 2022 and is headquartered in New York, NY.
Year: 2025
Translational Development Acquisition, Prologium Secure $50 Million Primary Capital Investment
Jul 28, 2:48 PM · MT Newswires
Translational Development Acquisition, ProLogium to Combine in $3.8 Billion Transaction
May 27, 12:28 PM · MT Newswires
Translational Development Acquisition Corp. (TDAC) stock is trading at US$10.86, -0.37% from the previous close of US$10.90.
The market cap for Translational Development Acquisition Corp. (TDAC) stock is approximately US$209.4M.
The 52-week high for Translational Development Acquisition Corp. (TDAC) stock is US$10.95.
The 52-week low for Translational Development Acquisition Corp. (TDAC) stock is US$10.34.
Translational Development Acquisition Corp. (TDAC) does not currently pay a dividend.
Stay on top of TDAC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
